Search
for
Sort by
Research 30 of 1000+
- Safety Profile and Efficacy of Biosea® Revive Serum for Hair Growth Through In Vitro Assessment and Clinical Evaluation
- Safety Evaluation of Topical Valproate Application
- Safety Evaluation of a Hair Regrowth Tonic Containing Swertia Extract
- LB1101 Evaluating the cardiovascular safety of low-dose oral minoxidil in patients with non-scarring alopecia: A retrospective cohort study
- An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjects
- Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation
- Drug safety evaluation of exemestane
- Evaluating safety and ethical implications of androgenetic alopecia treatments: a comparison of direct-to-consumer platforms and dermatologist visits
- 15485 Evaluating the safety and efficacy of intense pulsed light with radiofrequency in US patients with hidradenitis suppurativa: A split-body study
- Clinical evaluation of the efficacy and safety of ‘ThriveCo anti-dandruff pre-shampoo treatment,’ containing ZenscalpinTM in the management of scalp dandruff in healthy adults
- The Evaluation of Efficacy and Safety of Topical Saw Palmetto and Trichogen Veg Complex for the Treatment of Androgenetic Alopecia in Men
- Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia
- A comprehensive evaluation of safety and awareness in eyebrow microblading: a cross-sectional study
- EVALUATION OF SAFETY AND HAIR GROWTH PROMOTING ACTIVITY OF TRICHUP CAPSULE
- Comprehensive evaluation of clinical efficacy and safety of celecoxib combined with chemotherapy in management of gastric cancer
- Evaluation of the Safety and Effectiveness of Nutritional Supplements for Treating Hair Loss
- Evaluation of the safety and efficacy of a fractional picosecond 1064 nm laser for post‐acne erythema in adult Chinese patients
- Evaluation of the safety and efficacy of platelet-rich plasma in the treatment of female patients with chronic telogen effluvium: A randomised, controlled, double-blind, pilot clinical trial
- Evaluation of the safety and effectiveness of intradermal administration of QR678 Neo<sup>®</sup> hair growth factor formulation: A phase‐IV, open‐label, single‐arm multi‐ethnicity clinical trial
- EVALUATION OF EFFICACY AND SAFETY OF PLATELET RICH PLASMA (PRP) IN THE TREATMENT OF ANDROGENIC ALOPECIA AND BACTERIAL ULCERATIVE LESION
- Pilot Evaluation of the Efficacy and Safety of Xtressé™ Gummy-Based Nutraceutical Supplement in Women with Hair Loss
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Comparative Evaluation of the Efficacy and Safety of Oral Finasteride versus Oral Dutasteride in Male Androgenetic Alopecia: An 18-Month Prospective Interventional Study from a Tertiary Care Centre in Uttar Pradesh
- COMPARATIVE EVALUATION OF EFFICACY AND SAFETY OF TOPICAL METHOTREXATE WITH TRETINOIN VERSUS BETAMETHASONE WITH TRETINOIN IN PATIENTS OF ALOPECIA AREATA: A PROSPECTIVE RANDOMIZED DOUBLE-BLIND STUDY
- Evaluation of the safety and efficacy of concentrated growth factors for hair growth promotion in androgenetic alopecia patients: A retrospective single‐centre, single‐arm study
- Evaluation of the Safety and Effectiveness of Oral Minoxidil in Children: A Systematic Review
- Evaluation of efficacy and safety of scalp threading with polydioxanone (PDO) monofilament threads in the treatment of male androgenetic alopecia
- Evaluation of Efficacy and Safety of Oral Cyclosporine in the Treatment of Severe Alopecia Areata
- Evaluating the Safety of Intravenous Delivery of Autologous Activated Platelet-rich Plasma
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)